Le Lézard
Classified in: Health
Subject: SVY

Global Oligonucleotide Synthesis Market to Reach US$ 770 Mn by 2025 - Persistence Market Research


NEW YORK, January 17, 2018 /PRNewswire/ --

Oligonucleotides are short fragments of nucleic acids and play a major role in drug discovery and molecular diagnostic chip technology. Oligonucleotide synthesis occurs either commercially to provide services for various end users or individually via DNA synthesizers for self-consumption. The achievements of life sciences researchers and scientists in the recent years have expanded the understanding of biological systems at the molecular level, which has generated more opportunities and growth in life sciences research and applications.

     (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO )

Thus, there are continuous growth opportunities for key players in the global oligonucleotide synthesis market. A new research report by Persistence Market Research titled 'Oligonucleotide Synthesis Market: Global Industry Analysis 2012 - 2016 and Forecast 2017 - 2025' presents a complete overview of the global oligonucleotide synthesis market. According to the forecast, the global oligonucleotide synthesis market is expected to reach a market value of over US$ 770 Mn by 2025. The global market is expected to grow at an exceptional rate with a CAGR of 13.9% during the forecast period.

Global Oligonucleotide Synthesis Market Research Report Overview @ https://www.persistencemarketresearch.com/market-research/oligonucleotide-synthesis-market.asp

Global Oligonucleotide Synthesis Market: Drivers 

Primarily the global oligonucleotide synthesis market is helped by the increase in research activities all over the world. The government is also supporting the research processes taking place especially in the healthcare sector. Government initiatives aimed towards attracting foreign players by providing various grants and subsidies are expected to boost the entry of major market players in emerging countries, thereby driving the regional markets. The market also has a systematic distribution channel that helps in maintaining the proper flow of products in the market, which in turn helps in improving the demand for oligonucleotide synthesis.

However, the lack of a proper regulatory framework in emerging markets for pharmaceutical and molecular research activities is likely to hamper market revenue growth as the research activities for therapeutic applications of oligonucleotides also need to follow certain regulatory guidelines and absence of these guidelines restricts therapeutic research activities. This is expected to have a negative impact on the oligonucleotide synthesis market.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/3296

Global Oligonucleotide Synthesis Market: Segmental Analysis 

Based on Region, Asia Pacific is expected to dominate the global oligonucleotide synthesis market with a robust growth rate of 9.8% during the forecast period. However North America is expected to hold the maximum market value during the study period.

Based on Service Type, the custom oligonucleotide synthesis segment is expected to lead the global market during the forecast period.

On the basis of Application, the academic R&D segment dominates the global oligonucleotide synthesis market in terms of revenue with the highest growth rate and revenue share. The academic R&D segment is expected to witness a CAGR of 8.4% during the forecast period.

On the basis of End Users, the academic and research institutes segment dominates the global oligonucleotide synthesis market. The biopharmaceuticals companies segment is also expected to grow at a rate similar to academic and research institutes.

Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/market-research/oligonucleotide-synthesis-market/toc

Global Oligonucleotide Synthesis Market: Competition Scenario 

This comprehensive research report includes a brief profile of all the major players in the industry. Some of the top companies mentioned in the report include Integrated DNA Technologies, Inc., GenScript Biotech Corporation, Eurofins Scientific SE, Bioneer Corporation, Kaneka Corporation (Eurogentec), Biolegio B.V., Eton Bioscience, Inc., IBA GmbH, Quintara Biosciences, TriLink BioTechnologies, LLC etc.

 Get full Report Now @ https://www.persistencemarketresearch.com/checkout/3296

Persistence Market Research Overview 

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Email: [email protected]

PMR Latest News:  https://www.persistencemarketresearch.com/news



These press releases may also interest you

at 06:45
On April 17, FAIR Health hosted a webinar entitled "Fifteen Years of Advancing Health Literacy and Cost Transparency: A Free Webinar on FAIR Health's Award-Winning Consumer Resources." This webinar offered a comprehensive review of FAIR Health's...

at 06:41
Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Community Eye Care Specialists ("CECS") in its affiliation with EyeSouth Partners ("EyeSouth"). CECS is a leading comprehensive...

at 06:38
"According to the latest research study, the demand for Biologic Therapeutic Drugs: Technologies and Global Markets expected to grow from $452.9 in 2023 to reach $823.4 billion by the end of 2028 at a compound annual growth rate (CAGR) of 12.7%...

at 06:35
Morphoceuticals Inc., a new biotechnology company pioneering AI-guided electroceuticals for tissue repair and organ regeneration, today announced the appointment of veteran biotech executive Jim Jenson, PhD, as CEO. Jenson joins a growing team and...

at 06:35
"According to the latest research study, the...

at 06:31
Targeted nutrient support for Hormonal Balance, Egg Quality, Cycle Regularity and More...



News published on and distributed by: